Moderna

If cleared by the FDA, it will become the second Covid-19 vaccine available in the United States for teens under 18 along with Pfizer-BioNTech’s vaccine, which was authorized for adolescents ages 12 to 15 in May.

The world’s leading COVID-19 vaccines may offer lasting protection that diminishes the need for frequent booster shots

Moderna says its COVID-19 vaccine strongly protects kids as young as 12

President Joe Biden says the U.S. will share an additional 20 million doses of COVID-19 vaccines with the world in the coming six weeks

Moderna reported on Thursday that early data shows high effectiveness in its coronavirus vaccine trial in adolescents ages 12 to 17.

The company said a 50-microgram dose of its vaccine on already-vaccinated individuals generated a promising immune response against COVID-19 variants found in South Africa and Brazil.

Moderna released findings on Tuesday from its phase three trial which showed that its coronavirus vaccine is 90% effective at preventing infections and more than 95% effective against severe disease up to six months after the second dose.

With a third coronavirus vaccine now approved in the U.S., what is the difference between the vaccines and should you opt for one over the other?

Here’s where vaccination eligibility stands in every state:

New research suggests the protection the Moderna vaccine gives against COVID-19 lasts for at least six months. The report published Tuesday in the New England Journal of Medicine echoes what Pfizer said last week about its vaccine, which works in a similar way.

The Moderna vaccine offers protection against COVID-19 for at least six months, according to a report in the New England Journal of Medicine.

The agency said late Thursday it approved new vials from Moderna that can contain up to 15 doses each, compared with the original vials designed to hold 10 doses. Additionally, regulators said providers can safely extract up to 11 doses from the original 10-dose vials. Those changes will be added to instructions for health care workers.

Here’s what we know about each of the coronavirus vaccines, and where they’re being distributed.

Miami-Dade Mayor Daniella Levine Cava announces that county-run COVID-19 vaccine sites will drop eligibility to 40 and older on March 29.

Moderna says it is studying its coronavirus vaccine in children ages six months to 11 years old.

This makes the Johnson & Johnson vaccine the third vaccine to have emergency use authorization from the U.S. Food and Drug Administration.

The FDA could approve a new one-shot COVID vaccine by Friday, as Congress decides on COVID relief bill details. The Johnson & Johnson one-shot vaccine is over 20 percent less effective than Pfizer and Moderna’s, but still far better than a flu shot.

COVID-19 vaccine makers tell Congress to expect a big jump in the delivery of doses over the coming month.

The grim milestone means the U.S. continues to lead the world in overall cases and deaths.

If you’re 65 years of age or older, you will have first priority in receiving the COVID-19 vaccine, Gov. Ron DeSantis has announced. In South Florida, both Miami-Dade and Broward counties are offering the vaccine to seniors in the 65-and-older age bracket, but note that demand for the vaccine is currently outweighing supply. For real-time updates regarding vaccine availability, click…